• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肝硬化患者丙型肝炎病毒相关性原发性肝细胞癌。

Hepatitis C virus-associated primary hepatocellular carcinoma in non-cirrhotic patients.

机构信息

Department of Gastroenterology and Hepatology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA.

出版信息

Dig Dis Sci. 2012 Dec;57(12):3265-70. doi: 10.1007/s10620-012-2260-y. Epub 2012 Jun 14.

DOI:10.1007/s10620-012-2260-y
PMID:22695885
Abstract

BACKGROUND

There is limited literature on hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection in the absence of cirrhosis.

AIMS

To investigate the relationship between HCV and HCC in the absence of cirrhosis and to characterize patients with HCV infection presenting with HCC in the absence of cirrhosis.

METHODS

We identified all adult patients with histological confirmation of HCC between 1994 and 2007 (404 patients). A case-control design (four controls for each case with non-cirrhotic HCC) was chosen to compare characteristics and survival of HCV in HCC patients without (cases) and with (controls) cirrhosis. Conditional logistic regression analysis was used to identify factors independently associated with HCV in non-cirrhotic HCC.

RESULTS

Eighty-seven patients with non-cirrhotic HCC were identified, six (7 %) had HCV infection in comparison with 107 of 317 (55.7 %) with cirrhotic HCC (P < 0.001). Compared with the HCV-associated HCC cirrhotic group, patients with HCV-associated HCC in the absence of cirrhosis were more likely to present with a single nodule (100 vs. 66.7 %), larger nodule size (>5 cm) (100 vs. 16.7 %), and macrovascular invasion (66.7 vs. 17.4 %) at time of diagnosis. Four of six patients with HCV-associated HCC in the absence of cirrhosis where alive at three years (all had resection), which was better survival than for HCC arising in cirrhotic livers of HCV-infected individuals (66.7 vs. 39.1 %).

CONCLUSION

We found that HCV is responsible for a small minority of non-cirrhotic HCC cases representing an uncommon and poorly defined subgroup of HCC.

摘要

背景

在没有肝硬化的情况下,慢性丙型肝炎病毒(HCV)感染患者的肝细胞癌(HCC)文献有限。

目的

研究无肝硬化的 HCV 与 HCC 之间的关系,并对无肝硬化的 HCV 感染患者 HCC 患者的特征进行描述。

方法

我们确定了 1994 年至 2007 年期间所有经组织学证实的 HCC 成年患者(404 例)。选择病例对照设计(每个无肝硬化 HCC 病例 4 个对照),比较无肝硬化 HCC 患者(病例)和肝硬化患者(对照)的 HCV 特征和生存情况。采用条件逻辑回归分析确定与非肝硬化 HCC 中 HCV 独立相关的因素。

结果

确定了 87 例非肝硬化 HCC 患者,其中 6 例(7%)患有 HCV 感染,而 317 例肝硬化 HCC 患者中有 107 例(55.7%)患有 HCV 感染(P<0.001)。与 HCV 相关的肝硬化 HCC 组相比,无肝硬化 HCC 患者中更有可能表现为单个结节(100%比 66.7%)、更大的结节大小(>5cm)(100%比 16.7%)和大血管侵犯(66.7%比 17.4%)。在诊断时,无肝硬化 HCV 相关 HCC 患者中有 4 例(66.7%)仍存活,存活时间为 3 年(均接受了切除术),这比 HCV 感染的肝硬化肝脏中 HCC 患者的生存率(66.7%比 39.1%)要好。

结论

我们发现 HCV 导致一小部分非肝硬化 HCC 病例,代表了 HCC 一个罕见且定义不明确的亚组。

相似文献

1
Hepatitis C virus-associated primary hepatocellular carcinoma in non-cirrhotic patients.非肝硬化患者丙型肝炎病毒相关性原发性肝细胞癌。
Dig Dis Sci. 2012 Dec;57(12):3265-70. doi: 10.1007/s10620-012-2260-y. Epub 2012 Jun 14.
2
Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.乙型肝炎和丙型肝炎相关肝细胞癌手术治疗效果的差异:单一大西洋彼岸中心的回顾性分析。
Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917.
3
Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis.肝硬化慢性丙型肝炎病毒感染患者队列中的肝细胞癌监测。
J Gastrointest Cancer. 2020 Jun;51(2):461-468. doi: 10.1007/s12029-019-00255-4.
4
Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis.慢性丙型肝炎病毒感染无肝硬化患者的肝细胞癌。
World J Gastroenterol. 2010 Aug 28;16(32):4061-5. doi: 10.3748/wjg.v16.i32.4061.
5
A Potential Serum -glycan Biomarker for Hepatitis C Virus-Related Early-Stage Hepatocellular Carcinoma with Liver Cirrhosis.一种潜在的与丙型肝炎病毒相关的肝硬化早期肝细胞癌的血清糖链生物标志物。
Int J Mol Sci. 2020 Nov 24;21(23):8913. doi: 10.3390/ijms21238913.
6
Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand.新西兰慢性丙型肝炎病毒感染所致肝细胞癌患者的监测因素改变了结局。
J Viral Hepat. 2019 Dec;26(12):1372-1376. doi: 10.1111/jvh.13179. Epub 2019 Aug 13.
7
Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.血清微小RNA let-7a-1/let-7d/let-7f和miRNA 143/145基因表达谱作为丙型肝炎病毒诱导的肝细胞癌的潜在生物标志物
Asian Pac J Cancer Prev. 2020 Feb 1;21(2):555-562. doi: 10.31557/APJCP.2020.21.2.555.
8
Impact of the Uridine⁻Cytidine Kinase Like-1 Protein and IL28B rs12979860 and rs8099917 SNPs on the Development of Hepatocellular Carcinoma in Cirrhotic Chronic Hepatitis C Patients-A Pilot Study.尿苷⁻胞苷激酶样-1蛋白及IL28B基因rs12979860和rs8099917单核苷酸多态性对肝硬化慢性丙型肝炎患者肝细胞癌发生发展的影响——一项初步研究
Medicina (Kaunas). 2018 Sep 27;54(5):67. doi: 10.3390/medicina54050067.
9
Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.循环 miR-182 和 miR-150 作为埃及丙型肝炎病毒感染后肝硬化和肝细胞癌生物标志物的作用。
Virus Res. 2018 Aug 15;255:77-84. doi: 10.1016/j.virusres.2018.07.004. Epub 2018 Jul 9.
10
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.肝硬化患者与非肝硬化患者肝细胞癌的危险因素分析:一项对213例来自印度的肝细胞癌患者的病例对照研究。
J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. doi: 10.1111/j.1440-1746.2007.04908.x. Epub 2007 Jun 7.

引用本文的文献

1
Incidence and Clinical Features of Hepatitis C Virus-associated Hepatocellular Carcinoma Patients without Liver Cirrhosis in Hepatitis B Virus-endemic Area.乙肝病毒流行地区非肝硬化的丙型肝炎病毒相关肝细胞癌患者的发病率及临床特征
J Liver Cancer. 2021 Mar;21(1):34-44. doi: 10.17998/jlc.21.1.34. Epub 2021 Mar 31.
2
Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis.慢性丙型肝炎治愈患者的肝细胞癌:脂肪变性轻微。
Cancer Med. 2023 May;12(9):10175-10186. doi: 10.1002/cam4.5711. Epub 2023 Apr 20.
3
Hepatocellular Carcinoma in Non-cirrhotic Liver Arises with a More Advanced Tumoral Appearance: A Single-Center Cohort Study.

本文引用的文献

1
Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis.慢性丙型肝炎病毒感染无肝硬化患者的肝细胞癌。
World J Gastroenterol. 2010 Aug 28;16(32):4061-5. doi: 10.3748/wjg.v16.i32.4061.
2
Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis.丙型肝炎病毒在非肝硬化肝细胞癌患者中的流行率。
Am J Med Sci. 2010 Feb;339(2):169-73. doi: 10.1097/MAJ.0b013e3181c4af27.
3
Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.非肝硬化肝脏中的丙型肝炎相关肝细胞癌。
非肝硬化肝脏中的肝细胞癌具有更晚期的肿瘤表现:一项单中心队列研究。
Turk J Gastroenterol. 2021 Aug;32(8):685-693. doi: 10.5152/tjg.2021.20677.
4
Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.非肝硬化患者的肝细胞癌:纤维化分期分布、特征和生存情况。
Dig Dis Sci. 2022 Jun;67(6):2677-2687. doi: 10.1007/s10620-021-07048-5. Epub 2021 May 23.
5
Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review.非肝硬化肝脏与肝癌预后不良相关:文献综述。
Med Sci Monit. 2019 Sep 3;25:6615-6623. doi: 10.12659/MSM.915722.
6
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.非肝硬化肝脏中的肝细胞癌:全面综述
World J Hepatol. 2019 Jan 27;11(1):1-18. doi: 10.4254/wjh.v11.i1.1.
7
Diagnostic Value of Glypican3, Heat Shock Protein 70 and Glutamine Synthetase in Hepatocellular Carcinoma Arising in Cirrhotic and Non-Cirrhotic Livers.磷脂酰肌醇蛋白聚糖3、热休克蛋白70和谷氨酰胺合成酶在肝硬化和非肝硬化肝脏发生的肝细胞癌中的诊断价值
J Clin Exp Hepatol. 2018 Jun;8(2):173-180. doi: 10.1016/j.jceh.2017.09.005. Epub 2017 Oct 7.
8
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.肝炎病毒感染在肝细胞癌致癌起始中的意义。
World J Gastroenterol. 2016 Jan 28;22(4):1497-512. doi: 10.3748/wjg.v22.i4.1497.
9
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease.美国退伍军人中无肝硬化的肝细胞癌与非酒精性脂肪性肝病相关。
Clin Gastroenterol Hepatol. 2016 Jan;14(1):124-31.e1. doi: 10.1016/j.cgh.2015.07.019. Epub 2015 Jul 18.
Mod Pathol. 2010 Feb;23(2):276-83. doi: 10.1038/modpathol.2009.174. Epub 2009 Nov 20.
4
Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.代谢综合征患者的肝细胞癌常无明显肝纤维化而发生:一项病理分析。
Hepatology. 2009 Mar;49(3):851-9. doi: 10.1002/hep.22734.
5
Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?在无肝硬化的情况下,非酒精性脂肪性肝病会使患者易患肝细胞癌吗?
Arch Pathol Lab Med. 2008 Nov;132(11):1761-6. doi: 10.5858/132.11.1761.
6
[Hepatocellular carcinoma in the non-cirrhotic liver].非肝硬化肝脏中的肝细胞癌
Pathologe. 2008 Feb;29(1):47-52. doi: 10.1007/s00292-007-0953-3.
7
Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers.非肝硬化肝脏中肝细胞癌切除术后的生存率和复发率。
J Am Coll Surg. 2007 Jul;205(1):27-36. doi: 10.1016/j.jamcollsurg.2007.03.002.
8
Deaths: preliminary data for 2004.死亡情况:2004年初步数据。
Natl Vital Stat Rep. 2006 Jun 28;54(19):1-49.
9
Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival.非肝硬化肝脏中肝细胞癌的切除术:生存危险因素分析
J Am Coll Surg. 2005 Nov;201(5):663-70. doi: 10.1016/j.jamcollsurg.2005.06.265. Epub 2005 Sep 30.
10
Management of hepatocellular carcinoma.肝细胞癌的管理
Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933.